
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide.
BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries — experienced colleagues who move quickly, take ownership, and are fueling the company’s international growth.
At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world.
You will report to the Director, Accounting & Controlling, International and work closely with US Corporate Accounting, FP&A, Procurement, HR, external accounting and payroll providers, tax advisors, and auditors to support BridgeBio's mission of delivering transformative medicines to patients with genetic diseases and genetically driven cancers.
Your primary purpose will be to oversee accounting operations, financial reporting, statutory compliance, and internal controls across BridgeBio's international entities. You will lead month-end close activities, support audits and compliance requirements, and drive process improvements to ensure accurate, timely, and compliant financial reporting.
The ideal candidate is a detail-oriented, hands-on accounting professional holding a recognized professional accounting qualification (CPA, ACCA, Swiss CPA, Chartered Accountant, or equivalent), who combines strong accounting, audit, and compliance expertise with excellent communication skills and the ability to thrive in a fast-paced biotechnology environment.
Be a true business partner to the function and European leaders. The above job description documents the general nature and level of work but is not intended to be an exhaustive list of activities, duties, and responsibilities required of employees in this role. Therefore, the successful candidate is expected to perform all other duties as assigned or required, as training and experience allow.
This is an office-based role and requires in-office collaboration 2-3 days per week in our Zug, Switzerland Office.
We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
As a global company, our comprehensive benefits may vary based on location. We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
For Full-Time U.S Based Roles:
Financial & Rewards
Health & Well-Being
Skill Development & Career Paths:
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.
Between 730 - 730 employees
2014
$4,349,199,360
Post Ipo Debt
$550,000,000 USD
Post Ipo Debt
$500,000,000 USD
Post Ipo Debt
$500,000,000 USD
Post Ipo Equity
$250,000,000 USD
Post Ipo Equity
$250,000,000 USD
Post Ipo Debt
$1,250,000,000 USD
Post Ipo Debt
$1,250,000,000 USD
Post Ipo Equity
$250,000,000 USD
Post Ipo Equity
$250,000,000 USD
Post Ipo Equity
$150,000,000 USD
Post Ipo Equity
$150,000,000 USD
Post Ipo Debt
$750,000,000 USD
Post Ipo Debt
$750,000,000 USD
Post Ipo Debt
$250,000,000 USD
Post Ipo Debt
$250,000,000 USD
Post Ipo Debt
$475,000,000 USD
Post Ipo Debt
$475,000,000 USD
Series D
$299,200,000 USD
Series D
$299,200,000 USD
IPO
$0
Series C
$135,000,000 USD
Series C
$135,000,000 USD
Series B
$33,100,000 USD
Series B
$33,100,000 USD
Series B
$6,900,000 USD
Series B
$6,900,000 USD